Redox changes at the mitochondrial level and deficiency of SIRT3 have been associated with metabolic pathologies and endothelial dysfunction, thus increasing the interest toward the identification of mitochondrial targets and their involvement in chronic diseases [13,14]. This evidence concerns the gene SIRT3 and endothelial dysfunction.